dalteparin has been researched along with Epithelial Ovarian Cancer in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| " A dose-response effect was not identified." | 2.77 | Dalteparin low molecular weight heparin (LMWH) in ovarian cancer: a phase II randomized study. ( Elit, LM; Hoskins, P; Julian, DH; Julian, JA; Lee, AY; Levine, MN; Liaw, PC; Parpia, S; Swystun, LL, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elit, LM | 1 |
| Lee, AY | 1 |
| Parpia, S | 1 |
| Swystun, LL | 1 |
| Liaw, PC | 1 |
| Hoskins, P | 1 |
| Julian, DH | 1 |
| Julian, JA | 1 |
| Levine, MN | 1 |
1 trial available for dalteparin and Epithelial Ovarian Cancer
| Article | Year |
|---|---|
Dalteparin low molecular weight heparin (LMWH) in ovarian cancer: a phase II randomized study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bridged-Ring Compoun | 2012 |